Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 740 of 6351
-
New drug combo aims to shrink tough lung tumors
Disease control OngoingThe goal of this single arm, phase II clinical trial is to evaluate the efficacy and safety of cadonilimab (AK104) as induction and consolidation therapy in locally advanced/unresectable non-small cell lung cancer (NSCLC) patients treated with concurrent chemoradiotherapy. Parti…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can stem cell 'Messages' heal blood vessels after preeclampsia?
Disease control Recruiting now\--- Why Is This Study Being Done? Women who have preeclampsia during pregnancy face a much higher risk of heart disease later in life. Preeclampsia is a serious pregnancy condition that causes high blood pressure and damages blood vessels. Even after the baby is born, the bloo…
Phase 1/2 • Sponsor: Universitas Padjadjaran • Aim: Disease control
Last updated Jun 26, 2026 19:01 UTC
-
New hope for men with spread prostate cancer: targeted radiation may boost standard care
Disease control Recruiting nowThe purpose of this study is to find out if giving radiation therapy (RT) to areas of metastatic prostate cancer at the time a participant is diagnosed will help control disease better than the usual treatment. This treatment is called metastasis-directed radiotherapy (MDRT). Th…
Phase 2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including urothelial cancer. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) …
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aimed at Kidney-Lung crisis shows promise in trial
Disease control Stopped earlyApproximately 150 patients with acute kidney injury (AKI) associated with acute hypoxemic respiratory failure (AHRF) will be randomized at up to 40 sites. Patients will be randomly assigned to either Auxora or matching placebo. Study drug infusions will occur every 24 hours for f…
Phase 2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Lung cancer drug shows promise in stopping relapse after surgery
Disease control Recruiting nowTo explore the effectiveness of anlotinib hydrochloride capsule in postoperative non-pCR non-small cell lung cancer patients with adjuvant intensive therapy
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a chemo booster tame a tough lymphoma?
Disease control By invitation onlyThis trial was a prospective, multicenter, randomized, controlled Phase III clinical design to compare the efficacy and safety of decitabine combined with R-CHOP (R-CHOP-D) versus R-CHOP in the treatment of primary EBV+ diffuse large B-cell lymphoma (DLBCL). Sixty patients were …
Phase 3 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for bile duct cancer: triple therapy shows promise after chemo fails
Disease control CompletedIntrahepatic cholangiocarcinoma (ICC) is a malignant tumor of biliary epithelial cells that originates from the branches of the intrahepatic bile duct at the second level and above. Its incidence accounts for about 15%-20% of primary liver malignancies, showing a gradually increa…
Phase 2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Electric field therapy + chemo shows promise against pancreatic cancer
Disease control Recruiting nowThis is a single arm phase II study. All patients will receive 3 cycles of the treatment of nab-paclitaxel (Days 1, 8 and 15), gemcitabine (Days 1, 8 and 15), and TTFields (worn every day for at least 18 hours). Following the initial 3 cycles of gemcitabine/nab-paclitaxel/TTField…
Phase 2 • Sponsor: Ashish Manne • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Immune cell therapy takes on lupus in early trial
Disease control By invitation onlyPrimary objective: Safety and tolerability of NKX019, administered after lymphodepletion (LD). Secondary objectives: * Assess clinical activity of NKX019 in subjects with systemic lupus erythematosus (SLE) with or without active lupus nephritis (LN) * Characterize pharmacokinet…
Phase 1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
VR mirror therapy could help kids with anorexia face their fears
Symptom relief Recruiting nowThe age of onset of anorexia nervosa has been progressively decreasing in recent years. Also, the prevalence rates of childhood anorexia in many countries have grown significantly. This increase was already observed before the COVID-19 pandemic, but the confinements and the stres…
Sponsor: University of Barcelona • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Gut feeling: personalized bacteria may ease PTSD symptoms
Disease control OngoingThis cohort clinical trial (RAPID RECOVERY) investigates the role of gut microbiome in mental health and the effectiveness of personalized microbiome correction in individuals with post-traumatic stress disorder (PTSD). The study aims to: 1. identify associations between gut mic…
Sponsor: Uzhhorod National University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
A Pocket-Sized MRI for strokes? new device put to the test
Diagnosis CompletedTo assess the safety and feasibility of the Wellumio 'Axana' device in the hospital setting with healthy controls and patients.
Sponsor: Wellumio R&D Australia Pty Ltd • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
Diagnosis Recruiting nowOur study named Integrated Continuous glucose monitoring glycemic cHAracterization during Pregnancy in comparison with oral glucose tolerance test (I-CHAP) aims to establish much needed preliminary evidence in our Asian population to show the capabilities of CGM use and its wealt…
Sponsor: KK Women's and Children's Hospital • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Can a Boron-Based pill tame obesity and blood sugar?
Disease control CompletedThis study investigates the safety and efficacy of sodium pentaborate pentahydrate in improving the body weight and glycemic profile of patients with overweight or obesity compared to the placebo group.
Phase 1/2 • Sponsor: Tabriz University of Medical Sciences • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could unplugging for summer reshape teen brains?
Knowledge-focused CompletedThe goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-…
Sponsor: Sapien Labs • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can a simple test predict Alzheimer's before symptoms worsen?
Knowledge-focused Recruiting nowThe goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimer…
Sponsor: Norwegian University of Science and Technology • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Digital exercise: a new weapon against joint inflammation?
Disease control Recruiting nowThis protocol describes a 6-month randomised, controlled exercise trial in patients with axial spondyloarthritis (axSpA) with re-randomization after 3-months. The primary outcome of the trial (disease activity) will be evaluated at 3-months. The exercise programme on trial compri…
Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A tiny fish may pack a big punch against childhood malnutrition
Prevention CompletedThis randomized controlled trial evaluated the effectiveness of supplementing the diets of infants aged 6-7 months with small fish powder on growth outcomes in the Garoua 1st Health District, Northern Cameroon. A total of 240 infants were enrolled and randomly assigned to receive…
Sponsor: Centre for Food and Nutrition Research, Yaounde • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
Can a phenytoin gel speed healing after oral cancer surgery?
Symptom relief CompletedThis randomized, parallel-arm clinical trial evaluated whether a topical phenytoin-loaded hydrogel dressing could improve postoperative wound healing in patients undergoing surgical resection and reconstruction for locally advanced oral squamous cell carcinoma. Twenty-four partic…
Sponsor: Mansoura University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC